Stanford University Medical Center, Stanford (United States of America)
Member of:
Event: ESC Congress 2024
Topic: Renal Failure and Cardiovascular Disease
Session: Clinical trial updates on the GLP-1 receptor agonist, semaglutide
Event: ESC Congress 2023
Topic: Mobile Apps
Session: Cutting edge digital health for early detection and efficient diagnosis
Event: ESC Congress 2022
Topic: Renal Failure and Cardiovascular Disease
Session: Renal failure and cardiovascular disease 2
Event: ESC Congress 2020
Topic: Renal Failure and Cardiovascular Disease
Session: Cardiovascular Disease in Special Populations ePosters